Schmidt-Hansen, M, Bennett, MI orcid.org/0000-0002-8369-8349 and Hilgart, J (2015) Oxycodone for Cancer Pain in Adult Patients. Journal of the American Medical Association, 314 (12). pp. 1282-1283. ISSN 0098-7484
Abstract
Clinical Question: Is oxycodone associated with greater efficacy and fewer adverse events compared with alternative analgesics for cancer pain?
Bottom Line: Oxycodone was not associated with superior cancer pain relief or fewer adverse effects compared with other strong opioids, such as morphine or oxymorphone. However, the quality of the evidence was low.
Many patients with cancer experience moderate or severe pain requiring treatment with strong opioids. However, not all opioids are well tolerated by all patients. This JAMA Clinical Evidence Synopsis summarizes a published Cochrane review1 that examined the association of oxycodone (any formulation or route of administration) compared with placebo or an active drug (including alternative forms of oxycodone) for treating cancer pain in adults.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2015, American Medical Association (AMA). Reproduced in accordance with the publisher's self-archiving policy. |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) |
Funding Information: | Funder Grant number NIHR National Inst Health Research RP-PG-0610-10114 |
Depositing User: | Symplectic Publications |
Date Deposited: | 25 Sep 2015 12:20 |
Last Modified: | 01 Jun 2023 15:56 |
Status: | Published |
Publisher: | American Medical Association |
Identification Number: | 10.1001/jama.2015.8556 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:90252 |